I wonder if this has any legs?
http://adisinsight.springer.com/trials/700281603
Trial Profile
A phase III study of oral Nadolol (INV102) as a treatment for patients with COPD who cannot quit cigarette smoking.
Planning
Phase of Trial: Phase III
Latest Information Update: 08 Feb 2017
At a glance
Most Recent Events
- DrugsNadolol (Primary)
- IndicationsChronic obstructive pulmonary disease
- FocusTherapeutic Use
Restricted Access
- 08 Feb 2017New trial record
Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.
If you are a subscriber to this content then contact us at [email protected] so we can help
- Login with a username/password associated to an account with a valid subscription
- Contact your organization’s admin about adding this content to your AdisInsight subscription
- Request a trial
- Forums
- ASX - By Stock
- Phase 3 trial for inv 102 ?
IVX
invion limited
Add to My Watchlist
0.00%
!
12.5¢

I wonder if this has any legs?...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
12.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $10.59M |
Open | High | Low | Value | Volume |
13.0¢ | 13.5¢ | 12.5¢ | $15.62K | 118.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 213400 | 12.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
13.5¢ | 57707 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 213400 | 0.120 |
2 | 227489 | 0.115 |
3 | 20320 | 0.105 |
4 | 45300 | 0.100 |
1 | 51020 | 0.098 |
Price($) | Vol. | No. |
---|---|---|
0.135 | 57707 | 2 |
0.140 | 12162 | 2 |
0.145 | 32000 | 1 |
0.150 | 146065 | 4 |
0.155 | 110008 | 2 |
Last trade - 14.46pm 20/06/2025 (20 minute delay) ? |
Featured News
IVX (ASX) Chart |